Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 30, 2025 REDWOOD CITY, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Nasdaq: CHRS), today announced that its third quarter 2025 financial results will be released after market close on Thursday, November 6, 2025. Starting at 5:00 p.m. […]
Amaze Expands Into the Metaverse Through Strategic Partnership with Dubit Amaze and Dubit Join Forces to Build Immersive Brand Experiences Across Gaming Platforms GlobeNewswire October 30, 2025 NEWPORT BEACH, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”) a global leader in creator-powered commerce, today announced a strategic partnership with
GlobalFoundries and Silicon Labs Expand Partnership to Accelerate Wireless Connectivity Solutions and Strengthen U.S. Chip Manufacturing GlobeNewswire October 30, 2025 MALTA, N.Y. and AUSTIN, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) — GlobalFoundries (NASDAQ: GFS) (GF), one of the world's leading semiconductor manufacturers, and Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, today announced
Holley Performance Brands Demonstrates Strong Momentum and Product Innovation at SEMA 2025 Portfolio of iconic brands continues to cement Holley's aftermarket leadership and deliver comprehensive performance solutions for enthusiasts worldwide GlobeNewswire October 30, 2025 BOWLING GREEN, Ky., Oct. 30, 2025 (GLOBE NEWSWIRE) — Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions,
WPP plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – WPP GlobeNewswire October 30, 2025 LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against WPP plc (“WPP” or “the Company”) (NYSE: WPP) for violations of §§10(b)
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 30, 2025 THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior to market open. Management will conduct
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs) PDUFA Date Set for March 29, 2026 GlobeNewswire October 30, 2025 BEDFORD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling
InterDigital Announces Financial Results For Third Quarter 2025 GlobeNewswire October 30, 2025 New license agreements drive Revenue and EPS above increased outlookAnnualized recurring revenue1 at all-time high of $588 million, up 49% YoY WILMINGTON, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video, and AI technology research and development company,
Capital Clean Energy Carriers Corp. Announces Third Quarter 2025 Financial Results GlobeNewswire October 30, 2025 ATHENS, Greece, Oct. 30, 2025 (GLOBE NEWSWIRE) — Capital Clean Energy Carriers Corp. (the “Company”, “CCEC”, “we” or “us”) (NASDAQ: CCEC), an international owner of ocean-going vessels, today released its financial results for the third quarter ended September 30, 2025.
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting GlobeNewswire October 30, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or the “Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing